1David KJ, Philip JS, Carl PW, et al. High risk pregnangcy management options. New York: WB. Savnders, 1994. 947.
2Takushi M, Moromizato H, Sakumoto K,et al. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol Oncol, 2002,87:185-189.
3Madej JG Jr. Colposcopy monitoring in pregnancy complicated by CIN and early cervical cancer. Eur J Gynaecol Oncol, 1996,17:59-65.
4Sorosky JI, Squatrito R, Ndubisi. BU, et al. Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity. Gynecol Oncol, 1995 ;59:207-210.
5Sood AK, Sorosky JI, Mary N, et al. Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes. Obstet Gynecol,2000,95:832-838.
6Kirkup W, Singer A. Colposcopy in the management of the pregnant patient with abnormal cervical cytology. Br J Obstet Gynaecol, 1980,87: 322-325.
7Campion MJ, Sedlacek TV. Colposcopy in pregnancy. Obstet Gynecol Clin North Am, 1993,20:153-163.
8Melsheimer P, Rummel HH. CIN in der Schwangerschaft:Haufigkeit, Diagnostik und Therapie. Geburtshilfe-Frauenheilkd, 1994,54:151-154.
9Ahdoot D, Van Nostrand KM, Nguyen NJ. The effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period. Am J Obstet Gynecol, 1998, 178:1116-1120.
10Coppola A,Sorosky J,Casper R,et al. The clinical course of cervical carcinoma in situ diagnosed during pregnancy. Gynecol Oncol ,1997,67:162-165.